ARCHIVES

Drugs and Targets: FDA extends Lymphoseek label to include mapping in solid tumors

This article is from The Cancer Letter archive.

Vol. 40 No. 41 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Comprehensive Designation To MN Center; Bernardin Center Wins NCI Planning Grant

October 16, 1998

Pediatric Oncology Groups Plan To Merge, Citing Greater Cost Efficiencies, Leverage

August 7, 1998

On Capitol Hill: Cancer Organizations Push Congress For Payment Of Patient Care Costs In Trials

September 17, 1999

NCI To Recompete Smokeless Tobaccos RFA as PA

January 24, 1986

Sole Source Negotiations

October 17, 1975

Crout, Finkel Replaced at FDA; Hayes Combine Biologics, Drugs

April 2, 1982